mRNA Vaccines and Therapeutics Industry Forecast to Generate Over $72 Billion in Revenues by 2032 - Breakdown by Vaccine Type, Treatment Type, Vaccine Manufacturing, Application, End-user, and Region
December 11, 2024 04:18 ET
|
Research and Markets
Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "mRNA Vaccines and Therapeutics Market by Vaccine Type, Treatment Type, Vaccine Manufacturing, Application, End-user, and Region 2024-2032" report has...
Vietnam Human Vaccines Import Research Report 2024: United States, France, Belgium, Thailand, Netherlands, India Analysis 2021-2024 & Forecasts 2024-2033
October 31, 2024 10:28 ET
|
Research and Markets
Dublin, Oct. 31, 2024 (GLOBE NEWSWIRE) -- The "Vietnam Human Vaccines Import Research Report 2024-2033" report has been added to ResearchAndMarkets.com's offering.By the end of 2023, Vietnam's...
BlueWillow Biologics to Present Significant Progress on Its Novel Intranasal Vaccine Technology at World Vaccine Congress Europe
October 28, 2024 08:05 ET
|
BlueWillow Biologics
ANN ARBOR, Mich., Oct. 28, 2024 (GLOBE NEWSWIRE) -- BlueWillow Biologics, Inc., a clinical-stage biotech company pioneering the future of intranasal vaccines, today announced that the company will...
Vaccine Adjuvants Strategic Research Report 2024
September 05, 2024 04:05 ET
|
Research and Markets
Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvants - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Vaccine...
H1N1 Vaccines Strategic Research Report 2024: Increasing Influenza Outbreaks and Viral Mutations Accelerates Demand - Global Market Forecast to 2030
August 28, 2024 04:27 ET
|
Research and Markets
Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The "H1N1 Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for H1N1 Vaccines is...
Global Vaccine Adjuvants Market Size, Share & Industry Trends Analysis, 2023-2030, Featuring Profiles of GSK, Novavax, SPI Pharma (Associated British Foods), Agenus, and CSL Among Others
April 10, 2024 04:05 ET
|
Research and Markets
Dublin, April 10, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccine Adjuvants Market Size, Share & Industry Trends Analysis, 2023-2030" report has been added to ResearchAndMarkets.com's offering.The...
Vaccine Adjuvants Market Global Industry Analysis 2018-2028: Expanding Human Vaccine Adjuvants Segment and Rising Infectious Disease Threats Propel Market Advancements
February 21, 2024 11:34 ET
|
Research and Markets
Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ...
Vaccine Adjuvants Industry Forecast to 2034: A $7.36 Billion Market Opportunity, Dominated by Merck & Co, Thermo Fisher Scientific, and Pacific GeneTech
January 24, 2024 14:18 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccine Adjuvants Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global vaccine...
FLUAD QUADRIVALENT Drug Insight and Market Forecasts, 2019-2032: Focus on 6MM - United States, Germany, France, Italy, Spain and United Kingdom
December 12, 2023 04:53 ET
|
Research and Markets
Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "FLUAD QUADRIVALENT Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
Adjuvants Market Size to be Worth USD 7.9 billion by 2031, at a CAGR of 6.7%| Transparency Market Research, Inc.
December 01, 2023 10:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global adjuvants market is estimated to flourish at a CAGR of 6.7% from 2022 to 2031....